Patents Assigned to GEDEA BIOTECH AB
  • Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
    Patent number: 12226396
    Abstract: Pharmaceutical compositions and methods of using said pharmaceutical compositions are provided herein. A method of preventing preterm birth in a pregnant individual is also provided, said method comprising administering to said individual a pharmaceutical composition comprising a compound of Formula XX or a lactone thereof of formula XIX or XXI and preventing said preterm birth by said administration.
    Type: Grant
    Filed: February 2, 2023
    Date of Patent: February 18, 2025
    Assignee: Gedea Biotech AB
    Inventors: Ulf Ellervik, Olov Sterner, Helena Strevens, Sophie Manner
  • Glucono delta-lactone for treatment of vaginal fungal infections
    Patent number: 11696891
    Abstract: The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono ?-lactone, wherein the glucono ?-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono ?-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: July 11, 2023
    Assignee: Gedea Biotech AB
    Inventors: Ulf Ellervik, Olov Sterner, Helena Strevens, Sophie Manner
  • GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF MICROBIAL INFECTIONS
    Publication number: 20230181523
    Abstract: Pharmaceutical compositions and methods of using said pharmaceutical compositions are provided herein. A method of preventing preterm birth in a pregnant individual is also provided, said method comprising administering to said individual a pharmaceutical composition comprising a compound of Formula XX or a lactone thereof of formula XIX or XXI and preventing said preterm birth by said administration.
    Type: Application
    Filed: February 2, 2023
    Publication date: June 15, 2023
    Applicant: GEDEA BIOTECH AB
    Inventors: Ulf ELLERVIK, Olov STERNER, Helena STREVENS, Sophie MANNER
  • Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
    Patent number: 11612584
    Abstract: The present invention concerns a pharmaceutical composition comprising a compound of Formula I for use in the treatment and/or prevention of microbial infections. Furthermore, the present invention concerns a method for prevention and/or reduction of biofilm formation.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: March 28, 2023
    Assignee: Gedea Biotech AB
    Inventors: Ulf Ellervik, Olov Sterner, Helena Strevens, Sophie Manner
  • Vaginal Tablet Formulation
    Publication number: 20220193031
    Abstract: The present invention concerns a pharmaceutical composition comprising glucono-?-lactone, which is suitable for use in the treatment of vaginal microbial infections.
    Type: Application
    Filed: April 3, 2020
    Publication date: June 23, 2022
    Applicant: GEDEA BIOTECH AB
    Inventors: Ulf Ellervik, Sophie Manner, Olov Sterner, Helena Strevens, Nils-Olof Lindberg, Annette Säfholm
  • Glucono delta-lactone for treatment of vaginal fungal infections
    Patent number: 10993907
    Abstract: The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono ?-lactone, wherein the glucono ?-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono ?-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: May 4, 2021
    Assignee: Gedea Biotech AB
    Inventors: Ulf Ellervik, Olov Sterner, Helena Strevens, Sophie Manner
  • GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF MICROBIAL INFECTIONS
    Publication number: 20200253925
    Abstract: The present invention concerns a pharmaceutical composition comprising a compound of Formula I for use in the treatment and/or prevention of microbial infections. Furthermore, the present invention concerns a method for prevention and/or reduction of biofilm formation.
    Type: Application
    Filed: October 5, 2018
    Publication date: August 13, 2020
    Applicant: GEDEA BIOTECH AB
    Inventors: Ulf ELLERVIK, Olov STERNER, Helena STREVENS, Sophie MANNER